Light-operated blood glucose eyeshade device and system
By activating retinal ganglion cells through a light-controlled blood glucose eye mask device, and influencing blood glucose metabolism, the convenience and side effects of existing blood glucose control methods are resolved, enabling easy-to-implement blood glucose management.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- LIGHTWAVE INFORMATION TECHNOLOGY (SHENZHEN) CO LTD
- Filing Date
- 2025-05-16
- Publication Date
- 2026-04-28
AI Technical Summary
Existing blood glucose control measures, such as healthy diet and drug treatment, are difficult to maintain long-term, have significant side effects, and are economically burdensome. Therefore, we are seeking a convenient and easy-to-implement method for blood glucose control.
A light-controlled blood glucose eye mask device is provided, which uses an LED light panel to emit red light to activate photosensitive retinal ganglion cells (ipRGCs), transmit signals to a series of nerve nuclei in the hypothalamus and medulla oblongata, and affect the peripheral brown adipose tissue (BAT) to achieve blood glucose metabolism control.
It enables convenient blood sugar control, requiring only the user to wear a device, avoiding dietary restrictions and medication side effects, and reducing economic and psychological stress.
Smart Images
Figure CN224166734U_ABST
Abstract
Description
Technical Field
[0001] This utility model relates to the field of phototherapy technology, and in particular to a light-controlled blood glucose eye mask device and system. Background Technology
[0002] High blood sugar, or blood sugar levels higher than normal, can cause various health problems if the body is in a state of high blood sugar for a long period. These include increased risk of heart disease, stroke, and other cardiovascular problems, as well as diabetic neuropathy and diabetic retinopathy. Maintaining good blood sugar control is key to preventing these complications and typically includes a healthy diet, regular exercise, and the use of blood sugar-lowering medications. However, for many people, adhering to a strict diet plan long-term can be very challenging, and excessive restriction of certain food types can lead to nutritional imbalances and negatively impact health. Regular exercise presents a significant challenge to self-discipline and requires dedicated time or facilities for consistent physical activity. Taking blood sugar-lowering medications can cause side effects, including but not limited to gastrointestinal discomfort, weight gain, and hypoglycemia; some patients may also require long-term or even lifelong medication to maintain blood sugar levels, increasing both financial burden and psychological stress. Utility Model Content
[0003] The purpose of this invention is to overcome the shortcomings of existing blood glucose control measures, such as the difficulty in achieving healthy eating and exercise, and the side effects and long-term dependence of medications. This invention provides a light-controlled blood glucose eye mask device and system to achieve convenient and easy blood glucose control.
[0004] Firstly, this utility model provides a light-controlled blood glucose eye mask device, comprising: a middle shell, an LED light panel, and a rear shell. The middle shell and the rear shell are disposed on opposite sides of the LED light panel. A plurality of LED beads are disposed on the side of the LED light panel closest to the rear shell. The LED light panel is connected to the rear shell. The middle shell is connected to the rear shell and covers the LED light panel.
[0005] According to a preferred embodiment, the light-controlled blood glucose eye mask device further includes a front shell. The front shell is disposed on the side of the middle shell away from the LED light panel, and the front shell is connected to the middle shell.
[0006] According to a preferred embodiment, the light-controlled blood glucose eye mask device further includes a fixing plate. The fixing plate is disposed between the LED light panel and the rear housing, and is connected to the rear housing.
[0007] According to a preferred embodiment, the rear shell has a through hole. The fixing piece is annular and is mounted on the edge of the through hole.
[0008] According to a preferred embodiment, a limiting post is provided along the edge of the through hole. The fixing plate and the LED light panel are provided with positioning holes. The fixing plate and the LED light panel are connected to the limiting post through the positioning holes.
[0009] According to a preferred embodiment, the light-controlled blood glucose eye mask device further includes a buffer layer and a strap. The buffer layer is disposed on the side of the rear housing away from the LED light panel. The strap is connected to the rear housing.
[0010] According to a preferred embodiment, the front shell, the middle shell, the rear shell, and the fixing plate are all mirror-image sets. Furthermore, the front shell, the middle shell, and the rear shell are each hinged to the central shaft component.
[0011] According to a preferred embodiment, at least one of the front shells has a transparent insert at its center, the transparent insert being hinged to the front shell.
[0012] According to a preferred embodiment, the light emission wavelength of the LED beads includes at least one of 630-780nm, the total power of the plurality of LED beads is 3-10W; and when the plurality of LED beads emit light, the proportion of red light in the color temperature ratio is greater than 25%, and the proportion of blue light is less than 3%; the light energy intensity of the LED light panel is 2-60mW / cm². 2 The light energy and heat intensity of the LED light panel is 10–40 J / cm². 2 .
[0013] According to a preferred embodiment, the LED bead is a single-wavelength red LED bead with an emission wavelength of at least one wavelength in the 640-720nm band.
[0014] According to a preferred embodiment, the LED lamp bead is a broadband red LED lamp bead 120 with a light emission band of 630-720nm, a peak wavelength of 630-710nm, and a half-wave width greater than 30nm.
[0015] According to a preferred embodiment, the LED bead is a golden yellow LED bead 120 with a peak wavelength of 630-700nm and a half-wave width greater than 30nm.
[0016] According to a preferred embodiment, the LED beads have a color temperature of 1000K to 3200K, a peak wavelength of 630 to 780nm, and a half-wave width greater than 70nm.
[0017] Secondly, this utility model also provides a light-controlled blood glucose eye mask system. The light-controlled blood glucose eye mask system includes the light-controlled blood glucose eye mask device and a drive controller provided by this utility model. The drive controller is connected to the LED light panel via a data cable.
[0018] Compared with the prior art, the beneficial effects of this utility model are as follows:
[0019] The light-controlled blood glucose eye mask provided by this utility model can emit red light. When the user wears the eye mask correctly, the red light emitted by the eye mask can illuminate the human eye. The red light enters through the visual window and can directly activate photosensitive retinal ganglion cells (ipRGCs) (special photoreceptor cells). The signal is transmitted through the optic nerve to a series of nerve nuclei in the hypothalamus and medulla oblongata, and finally acts on the peripheral brown adipose tissue (BAT) through the sympathetic nerve. This can affect the ability of blood glucose metabolism, thereby achieving the effect of blood glucose control. Furthermore, when using this embodiment to lower blood glucose, the user only needs to wear the device, which is easy to implement. Attached Figure Description
[0020] Figure 1 This is an exploded view of the structure of a preferred embodiment of the light-controlled blood glucose eye mask device of this utility model;
[0021] Figure 2 This is a schematic diagram of an LED light board according to a preferred embodiment of the present invention;
[0022] Figure 3 This is a schematic diagram of a preferred embodiment of the light-controlled blood glucose eye mask system of this utility model.
[0023] Marked in the image:
[0024] Transparent insert 101, front shell 102, central shaft component 103, middle shell 104, LED light panel 105, fixing piece 106, rear shell 107, buffer layer 108, strap 109, drive controller 110, data cable 111, LED beads 120, terminal block 121. Detailed Implementation
[0025] The present invention will be further described in detail below with reference to specific embodiments. However, it should not be construed as limiting the scope of the present invention to the following embodiments; all technologies implemented based on the content of the present invention fall within the scope of the present invention.
[0026] Unless otherwise specified, the use of terms such as "upper," "lower," "left," "right," "center," "inner," and "outer" to indicate orientation or positional relationships in the description of specific embodiments of this utility model is based on the orientation or positional relationships shown in the accompanying drawings, or the orientation or positional relationship in which the utility model product / equipment / device is typically placed during use. These terms are merely for the purpose of facilitating the description of the utility model solution or simplifying the description in specific embodiments, enabling those skilled in the art to quickly understand the solution, and do not indicate or imply that a specific device / component / element must have a specific orientation, or be constructed and operated in a specific positional relationship. Therefore, they should not be construed as limitations on this utility model.
[0027] Furthermore, the use of terms such as "horizontal," "vertical," "suspended," "parallel," and "coaxial" does not imply that the corresponding device / component / element must be absolutely horizontal, vertical, suspended, parallel, or coaxial. Slight tilt or deviation is permissible, as long as it does not affect the normal function of the relevant component. For example, "horizontal" simply means that its direction is more horizontal relative to "vertical," not that the structure must be perfectly horizontal; a slight tilt is acceptable. "Coaxial" means that two components are arranged as coaxially as possible, allowing them to move coaxially or approximately coaxially when their relative positions change. Alternatively, it can be simplified to mean that the corresponding device / component / element, when arranged in "horizontal," "vertical," "suspended," "parallel," or "coaxial" directions, can have an error / deviation of ±10% relative to the corresponding direction, more preferably within ±8%, more preferably within ±6%, more preferably within ±5%, and more preferably within ±4%. For example, the deviation in the "coaxial" direction is controlled within 0.2-1mm, preferably within 0.2-0.5mm. As long as the corresponding device / component / element is within the error / deviation range, it can still achieve its function in the present invention.
[0028] Furthermore, the use of terms such as "first," "second," and "third" in terminology is merely for distinguishing descriptions of identical or similar components and should not be interpreted as emphasizing or implying the relative importance of a particular component.
[0029] Furthermore, in the description of the embodiments of this utility model, "several", "multiple", and "several" represent at least two. The number can be any number, such as two, three, four, five, six, seven, eight, or nine, and can even exceed nine.
[0030] Furthermore, in the description of the technical solution of this utility model, unless otherwise explicitly specified / limited / restricted, the terms "set up," "install," "connect," "link," "equipped with," "laid out," and "arranged" should be interpreted broadly. For example, they can refer to fixed connections, detachable connections, or integral connections; they can refer to common connection methods in the art, such as welding, riveting, bolting, and threaded connections. Such connections can be mechanical, electrical, or communication connections; they can be direct connections or indirect connections through an intermediate medium; and they can refer to the internal communication between two components.
[0031] Example 1
[0032] This invention provides a light-controlled blood glucose eye mask device. See also... Figure 1 The light-controlled blood glucose eye mask device includes: a middle shell 104, an LED light panel 105, and a rear shell 107. The middle shell 104 and the rear shell 107 are disposed on both sides of the LED light panel 105. A plurality of LED beads 120 are disposed on the side of the LED light panel 105 near the rear shell 107. The LED light panel 105 is connected to the rear shell 107. The middle shell 104 is connected to the rear shell 107 and covers the LED light panel 105. Preferably, the middle shell 104 and the rear shell 107 are snap-fitted together.
[0033] See Figure 2 Preferably, the LED light board 105 is a flexible circuit board. Preferably, the LED light board 105 includes two annular regions and a strip region connecting the two annular regions. Preferably, a plurality of LED beads 120 are arranged in the center of the annular regions of the LED light board 105. Preferably, the plurality of LED beads 120 arranged in the annular regions of the LED light board 105 are connected in series and parallel. And the power supply ports of the plurality of LED beads 120 on the LED light board 105 are led out from the strip region of the LED light board 105 and connected to an external power supply.
[0034] Preferably, the light-controlled blood glucose eye mask device further includes a front shell 102. The front shell 102 is disposed on the side of the middle shell 104 away from the LED light panel 105, and the front shell 102 is connected to the middle shell 104. Preferably, the front shell 102 and the middle shell 104 are engaged.
[0035] Preferably, the middle shell 104 is provided with a plurality of engaging positions for connecting with the front shell 102 and the rear shell 107. Preferably, the engaging positions for connecting the middle shell 104 with the front shell 102 and the rear shell 107 are located at the edge of the shell.
[0036] Preferably, the light-controlled blood glucose eye mask device further includes a fixing piece 106. The fixing piece 106 is disposed between the LED light panel 105 and the rear shell 107. And the fixing piece 106 is connected to the rear shell 107.
[0037] Preferably, the rear shell 107 has a through hole. The fixing piece 106 is annular and is mounted on the edge of the through hole. Preferably, a limiting post is provided on the edge of the through hole. The fixing piece 106 and the LED light panel 105 are provided with positioning holes. The fixing piece 106 and the LED light panel 105 are connected to the limiting post through the positioning holes. Preferably, the fixing piece 106 is positioned in the light emission direction of the LED light panel 105. Preferably, the fixing piece 106 is coaxial with the annular area of the LED light panel 105. Preferably, the fixing piece 106 is made of transparent material for the protection of the LED beads 120.
[0038] Preferably, the light-controlled blood glucose eye mask device further includes a buffer layer 108 and a strap 109. The buffer layer 108 is disposed on the side of the rear shell 107 away from the LED light panel 105. The strap 109 is connected to the rear shell 107. Preferably, the front shell 102, the middle shell 104, the rear shell 107, and the fixing piece 106 are all mirror images of each other. Furthermore, the front shell 102, the middle shell 104, and the rear shell 107 are each hinged to the central shaft component 103.
[0039] Preferably, the two ends of the strap 109 are respectively connected to different back shells 107. The buffer layer 108 is made of elastic materials such as leather, sponge, and rubber. Preferably, the buffer layer 108 is laid along the edge of the back shell 107. Preferably, the user wears the light-controlled blood glucose eye mask device through the strap 109. Preferably, the strap 109 can be an elastic band, belt, or other adjustable strap, and the adjustment method includes, but is not limited to, Velcro, buckles, and binding. Preferably, when the user wears the light-controlled blood glucose eye mask device, the buffer layer 108 contacts the user's eye socket to avoid excessive pressure.
[0040] Preferably, at least one front housing 102 has a transparent insert 101 at its center, and the transparent insert 101 is hinged to the front housing 102. Preferably, a front housing 102 has a transparent insert 101 at its center. Preferably, the transparent insert 101 can be used to engrave brand logos or personalized logo content.
[0041] The LED beads 120 emit wavelengths including at least one of 630-780nm, and the total power of a plurality of LED beads 120 is 3-10W; and when a plurality of LED beads 120 emit light, the proportion of red light in the color ratio is greater than 25% and the proportion of blue light is less than 3%; the light energy intensity of the LED light board 105 is 2-60mW / cm2; and the light energy heat intensity of the LED light board 105 is 10-40J / cm2.
[0042] Preferably, the LED bead 120 is a single-wavelength red LED bead 120 with an emission wavelength of at least one wavelength in the 640-720nm band.
[0043] Preferably, the LED bead 120 is a broadband red LED bead 120 with a light emission band of 630-720nm, a peak wavelength of 630-710nm, and a half-wave width greater than 30nm.
[0044] Preferably, the LED bead 120 is a golden yellow LED bead 120 with a peak wavelength of 630-700nm and a half-wave width greater than 30nm.
[0045] Preferably, the LED bead 120 has a color temperature of 1000K to 3200K, a peak wavelength of 630 to 780nm, and a half-wavelength greater than 70nm.
[0046] Preferably, when using the light-controlled blood glucose eye mask device, the user places the eye mask in front of their eyes, with the eye socket in contact with the buffer layer 108. The light-controlled blood glucose eye mask device is fixed to the eye by the strap 109, so that the light emitted from the LED light panel 105 can illuminate the human eye. The red light enters the user's visual window and directly activates photosensitive retinal ganglion cells (ipRGCs) (special photoreceptor cells). The signal is transmitted through the optic nerve to a series of nerve nuclei in the hypothalamus and medulla oblongata, and finally acts on the peripheral brown adipose tissue (BAT) through the sympathetic nerve. This can affect the ability of blood glucose metabolism, thereby achieving the effect of blood glucose control. Furthermore, when using this embodiment to lower blood glucose, the user only needs to wear the device, which is easy to implement.
[0047] Example 2
[0048] This embodiment provides a light-controlled blood glucose eye mask system. See also... Figure 3 The light-controlled blood glucose eye mask system includes a light-controlled blood glucose eye mask device and a drive controller 110. Preferably, in this embodiment, the light-controlled blood glucose eye mask device is the light-controlled blood glucose eye mask device involved in Example 1.
[0049] Preferably, the drive controller 110 is connected to the LED light board 105 via a data cable 111. Preferably, the drive controller 110 is used to supply power to the LED light board 105 and to control the light emission mode of the LED beads 120, such as flashing frequency, light emission duration, and light emission intensity.
[0050] Preferably, when using the light-controlled blood glucose eye mask system, after wearing the device, the user controls the LED beads 120 on the LED light panel 105 to emit light via the drive controller 110. This causes the red light emitted by the LED light panel 105 to enter the visual window, activating photosensitive retinal ganglion cells (ipRGCs, special photoreceptor cells). The signal is transmitted through the optic nerve to a series of nerve nuclei in the hypothalamus and medulla oblongata, and finally acts on the peripheral brown adipose tissue (BAT) through the sympathetic nervous system, thus affecting the blood glucose metabolism capacity and achieving blood glucose control.
[0051] The above description is only a preferred embodiment of the present utility model and is not intended to limit the present utility model. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present utility model should be included within the protection scope of the present utility model.
Claims
1. A light-controlled blood glucose eye mask device, characterized in that, include: The middle shell (104), the LED light panel (105), and the rear shell (107); The middle shell (104) and the rear shell (107) are disposed on both sides of the LED light panel (105); The LED light panel (105) is provided with a plurality of LED beads (120) on the side near the rear shell (107); The LED light panel (105) is connected to the rear shell (107). The middle shell (104) is connected to the rear shell (107) and covers the LED light panel (105).
2. The light-controlled blood glucose eye mask device according to claim 1, characterized in that, It also includes a front shell (102); the front shell (102) is disposed on the side of the middle shell (104) away from the LED light panel (105), and the front shell (102) is connected to the middle shell (104).
3. The light-controlled blood glucose eye mask device according to claim 2, characterized in that, It also includes a fixing piece (106); the fixing piece (106) is disposed between the LED light panel (105) and the rear shell (107); and the fixing piece (106) is connected to the rear shell (107).
4. The light-controlled blood glucose eye mask device according to claim 3, characterized in that, The rear shell (107) has a through hole; The fixing piece (106) is configured as an annular shape, and the fixing piece (106) is mounted on the edge of the through hole.
5. The light-controlled blood glucose eye mask device according to claim 4, characterized in that, A limiting post is provided along the edge of the through hole; the fixing plate (106) and the LED light board (105) are provided with positioning holes; the fixing plate (106) and the LED light board (105) are connected to the limiting post through the positioning holes.
6. The light-controlled blood glucose eye mask device according to claim 5, characterized in that, It also includes a buffer layer (108) and a strap (109); The buffer layer (108) is disposed on the side of the rear shell (107) away from the LED light panel (105); The strap (109) is connected to the rear shell (107).
7. The light-controlled blood glucose eye mask device according to claim 6, characterized in that, The front shell (102), the middle shell (104), the rear shell (107), and the fixing piece (106) are all mirror images of each other; and the front shell (102), the middle shell (104), and the rear shell (107) are respectively hinged to the central shaft component (103).
8. The light-controlled blood glucose eye mask device according to claim 7, characterized in that, At least one of the front shells (102) has a transparent insert (101) at its center, the transparent insert (101) being hinged to the front shell (102).
9. The light-controlled blood glucose eye mask device according to claim 1, characterized in that, The light emission wavelength of the LED beads (120) includes at least one of 630-780nm, and the total power of the plurality of LED beads (120) is 3-10W; and when the plurality of LED beads (120) emit light, the proportion of red light in the color ratio is greater than 25%, and the proportion of blue light is less than 3%; the light energy intensity of the LED light panel (105) is 2-60mW / cm². 2 The light energy and heat intensity of the LED light panel (105) is 10-40 J / cm². 2 .
10. A light-controlled blood glucose eye mask device according to claim 9, characterized in that, The LED bead (120) is a single-wavelength red LED bead (120) with an emission wavelength of at least one wavelength in the 640-720nm band.
11. A light-controlled blood glucose eye mask device according to claim 9, characterized in that, The LED bead (120) is a broadband red LED bead (120) with a light emission band of 630-720nm, a peak wavelength of 630-710nm, and a half-wave width greater than 30nm.
12. A light-controlled blood glucose eye mask device according to claim 9, characterized in that, The LED bead (120) is a golden yellow LED bead (120) with a peak wavelength of 630-700nm and a half-wave width greater than 30nm.
13. A light-controlled blood glucose eye mask device according to claim 9, characterized in that, The LED beads (120) have a color temperature of 1000K to 3200K, a peak wavelength of 630 to 780nm, and a half-wave width greater than 70nm.
14. A light-controlled blood glucose eye mask system, characterized in that, The light-controlled blood glucose eye mask system includes the light-controlled blood glucose eye mask device as described in any one of claims 1 to 9 and a drive controller (110); the drive controller (110) is connected to the LED light panel (105) via a data cable (111).